By Daniel Sabet, CPA · Senior Manager, CFO, GreenGrowth CPAs · 280E, Tax Strategy & Growth Planning · Los Angeles, CA | Published June 2026 | Updated November 2026 | Cannabis Tax
Update, November 2026: the September 15 Q3 estimated tax deadline and the July 6, 2026 retroactive R&D election window under Rev. Proc. 2025-28 have passed. The COGS review, depreciation timing, PTET and state conformity steps below still apply to year-end planning.
GreenGrowth CPAs is a PCAOB-registered CPA firm that specializes in cannabis tax and accounting for licensed operators in every state with a legal cannabis market. Mid-year tax planning for cannabis operators is not a nice-to-have — it is the mechanism that determines whether you protect your margins or spend Q4 reacting to damage that was preventable in June. I work with cannabis dispensaries, cultivators, and multi-state operators across California, New York, New Jersey, Minnesota, and Delaware, and the pattern is identical every year: the operators who avoid year-end surprises ran a structured mid-year review in June or July. The ones who scramble waited until November. By then, most of the meaningful options are gone. This checklist covers the six moves every cannabis operator should complete before the end of summer 2026.
QUICK ANSWER
The most important mid-year tax planning actions for cannabis operators in 2026 are: recalibrating your Q3 estimated payment before September 15, validating your COGS categorization under 280E, modeling bonus depreciation timing for any H2 equipment purchases, and — before it closed on July 6, 2026 — evaluating the retroactive R&D election window under Rev. Proc. 2025-28 for tax years 2022–2024.
Mid-Year Tax Planning for Cannabis: At a Glance
- What it is: A structured review of your tax position, open deadlines, and deduction opportunities conducted between June and August — before the Q3 estimated payment window closes and H2 capital decisions are made.
- Who it applies to: All licensed cannabis operators — dispensaries, cultivators, processors, distributors, and MSOs operating in any legal U.S. market.
- Key constraint: Under IRC Section 280E, cannabis businesses cannot deduct most ordinary business expenses at the federal level. Cost of goods sold is the primary exception. COGS must be structured correctly throughout the year — retroactive fixes at year-end are limited.
- Primary mistake: Treating tax planning as a Q4 activity. Most high-value windows — estimated payment recalibration, depreciation elections, R&D filings — close before October.
- Relevant thresholds: September 15 Q3 estimated tax deadline; July 6 R&D retroactive election window (Rev. Proc. 2025-28); $2.5M Section 179 cap and 100% bonus depreciation under OBBBA.
- GreenGrowth’s role: We conduct mid-year tax reviews for cannabis operators across our five primary markets, mapping your book position against federal and state deadlines to identify every remaining 2026 window.
Ready to review your mid-year position? Book a CFO Discovery Call with our team →
1. Recalibrate Your Q3 Estimated Tax Payment Before September 15
The federal Q3 estimated tax payment deadline is September 15, 2026 — and it is the most consistently missed window in cannabis. Most operators set estimated payments based on a January projection or prior-year income and never revisit them. By mid-year, that number is often wrong in one direction or the other. If your revenue grew faster than projected, you are underpaying and building toward a penalty. If a new location underperformed or a state delayed licensing, you may be overpaying and tying up cash unnecessarily.
The practical step is straightforward: get your books current through June 30, run a revised full-year income projection using H1 actuals plus a realistic H2 forecast, and compare your projected annual tax liability against what you have already paid in Q1 and Q2 estimated payments. The gap is your minimum Q3 payment. IRS underpayment penalties under IRC Section 6654 apply when your total payments fall below 90% of current-year liability or 100% of prior-year liability (110% if prior-year AGI exceeded $150,000). Cannabis operators in California, New Jersey, and New York also need to layer in state estimated payment requirements, which have their own due dates and calculation rules.
2. Review Your COGS Categorization
Under IRC Section 280E, cannabis businesses operating in Schedule I controlled substance sales cannot deduct most ordinary and necessary business expenses at the federal level. The exception is cost of goods sold under IRC Section 471 — which is not technically a “deduction” but a reduction in gross income. COGS is where the majority of your mid-year tax planning for cannabis should be focused.
The mid-year COGS review has two objectives. First, confirm that all allowable costs are being captured and coded correctly in your chart of accounts. In practice, COGS categorization drifts — not because anyone made a bad decision, but because day-to-day coding does not always match the tax policy. Second, for vertically integrated operators (cultivators that also retail, or processors that distribute), confirm that indirect production costs — allocated labor, packaging, facility overhead tied to production — are flowing through COGS correctly and are documented in a way that is defensible under IRS scrutiny. See our cannabis-specific tax compliance page for how we structure this review.
💬 The Conversation Worth Having
Most cannabis operators I talk to in Q3 are surprised to discover their COGS categorization has drifted since Q1 — not because anyone made bad decisions, but because nobody was reviewing it monthly. In a hypothetical example (not a client result), a California vertically integrated operator recovered $40,000 in miscategorized indirect costs in a mid-year review — costs that had been coded to operating expenses all year when they should have flowed through COGS. That is a real deduction recovered through structured attention in June, not a year-end scramble.
3. Model Bonus Depreciation Timing Before You Buy Equipment in H2
The One Big Beautiful Bill Act (OBBBA, P.L. 119-21, signed July 4, 2025) permanently restored 100% first-year bonus depreciation under IRC Section 168(k) for qualifying property acquired and placed in service after January 19, 2025. The Section 179 expensing cap also increased to $2.5 million under OBBBA, with a phase-out beginning at $4 million in total property placed in service. For cannabis operators planning equipment purchases in H2, these changes create real first-year deduction power — but the analysis has to happen before the purchase, not after.
The two issues that require pre-purchase analysis: First, the 280E filter. Bonus depreciation is only as useful as the deduction it produces after the 280E analysis. Equipment tied to cultivation, extraction, or processing generally flows through COGS and produces real tax benefit. Equipment tied to retail/dispensary functions faces 280E deduction limits that reduce the effective benefit. Second, the placed-in-service rule. An asset must be operational before December 31 to take the depreciation deduction in the current tax year. “Ordered” or “delivered” does not qualify. If a piece of equipment is not up and running before year-end, the deduction moves to 2027. Confirm vendor delivery and installation timelines before signing any Q4 purchase agreements.
Also critical for California, New York, and New Jersey operators: those states have not conformed to the OBBBA’s bonus depreciation restoration. Federal 100% bonus depreciation does not automatically flow through to your state return in these markets. Separate state depreciation schedules are required.
Planning any equipment purchases in H2 2026? We can model the 280E interaction and placed-in-service timeline before you commit.
Book a Review →4. Check the July 6 R&D Retroactive Election Window
IRS Revenue Procedure 2025-28 (issued August 28, 2025) created a one-time window for eligible small businesses to make retroactive elections to immediately expense domestic research and experimental costs for tax years 2022, 2023, and 2024, rather than the multi-year amortization that was required under prior law. The window closes July 6, 2026 — or the earlier expiration of the statute of limitations under IRC Section 6511 for each individual year.
For cannabis operators, qualifying domestic R&D activities may include extraction method development, product formulation and testing, cultivation process optimization, and compliance technology development. Eligibility requires average annual gross receipts of $31 million or less for 2022–2024 under the Section 448(c) gross receipts test, aggregated across all related entities. The 280E interaction applies and must be analyzed alongside the R&D election — this is not a simple “file and collect” situation. But for operators who conducted qualifying research, this may be one of the most underutilized windows in cannabis tax right now.
One important catch: if your 2022 federal return was originally filed on April 15, 2023 without an extension, your Section 6511 statute of limitations for that year expired April 15, 2026 — before July 6. Do not assume July 6 is your universal deadline without confirming the actual filing date for each year.
5. Evaluate Your Entity Structure Before Year-End
Entity structure decisions made in June are strategic. Made in November, they are reactive — and often impractical given compliance lead times. If your cannabis operation expanded into a new state, added a license type, crossed a revenue milestone, or changed ownership composition in the first half of 2026, the structure you started the year with may be generating unnecessary tax drag.
The OBBBA’s changes to the SALT deduction — $40,400 cap in 2026, phasing out at $505,000 MAGI, reverting to $10,000 in 2030 — add new analysis layers for multi-owner cannabis operations structured as LLCs, S-Corps, or partnerships. The pass-through entity tax (PTET) election, available in 36 jurisdictions including New York, New Jersey, and California, allows entity-level state tax payments to be deducted as a business expense — bypassing the personal SALT cap entirely. This election must generally be made and estimated payments started during the tax year. Mid-year 2026 is the window to confirm it is in place.
6. Build Your State Compliance Calendar for H2 2026
Multi-state cannabis operators face a compliance calendar that does not mirror the federal timeline. Each state where you hold an active license has its own estimated tax payment schedule, excise tax filing deadlines, and license renewal requirements.
California: CDTFA cannabis excise tax filings are quarterly. Q2 2026 returns are generally due by July 31. California does not conform to federal bonus depreciation under OBBBA — separate state depreciation schedules are required for all assets claimed federally.
New York: New York does not conform to federal bonus depreciation. PTET election and estimated payment requirements for New York pass-through entities should be reviewed and confirmed mid-year. OCM compliance deadlines vary by license type.
New Jersey, Minnesota, Delaware: Each state has its own conformity position on OBBBA provisions — confirm with your cannabis CPA before assuming any federal change flows through at the state level.
▶ Benchmark: Mid-Year Review vs. No Mid-Year Review
No Mid-Year Review
- Q3 payment based on January projection — likely wrong
- COGS drift undetected until year-end
- Bonus depreciation timing decided after asset acquired
- July 6 R&D window missed entirely
- State deadlines discovered reactively in Q4
With Mid-Year Review
- Q3 payment recalibrated on H1 actuals
- COGS review catches miscategorizations before they compound
- Equipment purchases timed for maximum deduction
- R&D eligibility confirmed and amended return filed if warranted
- H2 state calendar mapped and in place
Related resource: GreenGrowth CPAs accounting and financial services for cannabis operators →
KEY TAKEAWAYS
- ›September 15 is the Q3 estimated tax deadline. If your income has shifted since January, recalibrate before then — not after.
- ›COGS is your primary 280E deduction lever. A mid-year categorization review catches drift before it compounds into a year-end problem.
- ›100% bonus depreciation is restored under OBBBA. For cannabis operators, the 280E interaction and placed-in-service date both require analysis before you make H2 capital purchases — not after.
- ›The retroactive R&D election window under Rev. Proc. 2025-28 closed on July 6, 2026. Cannabis operators who conducted qualifying domestic R&D in 2022–2024 and had gross receipts under $31M may have unclaimed relief.
- ›PTET elections for NY, NJ, and CA pass-through entities bypass the personal SALT cap under OBBBA. These elections must be made during the tax year — mid-year 2026 is the confirmation window.
- ›CA, NY, and NJ do not conform to OBBBA bonus depreciation. Operators in these states must maintain separate federal and state depreciation schedules for any asset claimed under OBBBA.
Frequently Asked Questions
The federal Q3 2026 estimated tax deadline is September 15, 2026 for most individuals, pass-through owners, and corporations. This applies to cannabis operators structured as sole proprietors, S-Corps, partnerships, and LLCs taxed as pass-throughs. C-Corp estimated payments use a different schedule. IRS underpayment penalties under Section 6654 apply when total payments fall below 90% of current-year liability or 100% of prior-year liability.
State estimated tax deadlines do not always align with the federal September 15 date. California, New York, and New Jersey each have their own quarterly estimated payment schedules and calculation methods. Multi-state cannabis operators need to confirm each state’s Q3 deadline separately — do not assume federal timing applies.
IRC Section 280E disallows federal deductions for businesses engaged in trafficking Schedule I or II controlled substances. State-licensed medical marijuana moved to Schedule III on April 28, 2026; adult-use cannabis remains Schedule I under federal law. The primary exception is cost of goods sold under IRC Section 471, which reduces gross income rather than being claimed as a standard deduction. This makes COGS the central tax planning variable for every cannabis business.
Mid-year tax planning under 280E focuses on ensuring COGS categorization is complete and accurate as of June 30, so that the Q3 estimated tax calculation reflects your actual deductible position. An incorrect COGS categorization in June compounds across H2. A mid-year COGS review gives you time to correct it before year-end, when retroactive fixes are limited and more expensive.
Yes. The 100% bonus depreciation restored under the OBBBA (P.L. 119-21) is not limited to specific industries — cannabis dispensaries can claim it on qualifying assets acquired and placed in service after January 19, 2025. The critical limitation is how 280E filters the effective tax benefit. Depreciation on assets tied to retail/dispensary functions faces 280E restrictions because those functions are the “trafficking” activity 280E addresses. The deduction can still be claimed on the federal return, but the taxable income it offsets is limited by 280E’s disallowance framework.
For dispensaries in California, New York, or New Jersey, the analysis is compounded by state non-conformity: those states do not follow the OBBBA’s federal bonus depreciation rules. Separate state depreciation schedules are required. A dispensary that claims 100% federal bonus depreciation on retail improvements will still depreciate those same improvements over their standard MACRS life for state purposes.
IRS Revenue Procedure 2025-28, issued August 28, 2025, established a one-time window for eligible small businesses to make retroactive elections under Section 174A and Section 280C related to R&D expense treatment for tax years 2022–2024. The window closes July 6, 2026 — or the earlier expiration of the statute of limitations under IRC Section 6511 for each individual tax year. Cannabis operators are not excluded from this provision. Qualifying activities may include extraction method development, cultivation process R&D, product formulation, and compliance technology development.
Eligibility requires average annual gross receipts of $31 million or less for 2022–2024, aggregated across all related entities under Section 448(c). The 280E interaction must be analyzed before filing — R&D costs allocable to COGS-eligible production functions have a different treatment path than R&D costs tied to disallowed functions. An important catch: if your 2022 federal return was filed on April 15, 2023 without extension, the three-year statute of limitations for that year may have expired April 15, 2026 — before July 6.
A pass-through entity tax (PTET) election allows an S-Corp, partnership, or LLC to pay state income taxes at the entity level as a deductible business expense, rather than having the income pass through to the owners for personal taxation. The entity-level payment bypasses the personal SALT deduction cap — which is $40,400 for joint filers in 2026 under OBBBA and phases out beginning at $505,000 MAGI. For cannabis owners in high-tax states with MAGI above the phase-out threshold, the PTET election can preserve significant deductions that the personal SALT cap would otherwise eliminate.
PTET elections are available in 36 jurisdictions, including New York, New Jersey, California, and Minnesota. The election must generally be made and estimated payments started during the tax year. A cannabis owner who has not confirmed their PTET election status by mid-year 2026 may lose the ability to use it effectively for the 2026 tax year. This is one of the most high-value conversations a cannabis owner should be having with their CPA right now.
Our mid-year tax reviews for cannabis clients cover five areas: (1) Q2 income and expense reconciliation against the prior projection, with a revised full-year income estimate and updated Q3 estimated payment calculation; (2) COGS categorization review to identify any drift from the documented COGS policy and confirm all allowable costs are captured; (3) OBBBA opportunity assessment, including bonus depreciation timing for any planned H2 capital purchases and Section 179 vs. bonus depreciation optimization; (4) July 6 R&D election eligibility review for qualifying operators; and (5) state-level compliance calendar for all active markets.
The goal is to exit the mid-year review with a clear Q3 payment number, a validated COGS position, a list of H2 tax moves to execute before December 31, and a complete H2 deadline calendar across all active states. We work with cannabis operators across California, New York, New Jersey, Minnesota, and Delaware. To schedule a review, visit our CFO Discovery Call page.
Your Mid-Year Window Is Open. Let’s Use It.
GreenGrowth CPAs runs mid-year tax reviews for cannabis operators across California, New York, New Jersey, Minnesota, and Delaware. We recalibrate your Q3 payment, validate your COGS position, model H2 depreciation opportunities, and map every deadline across your active states. One conversation in June is worth more than a year-end scramble in November.
Book a CFO Discovery Call →Learn About Our Services →
KEY NUMBERS
Mid-Year Is When Cannabis Tax Planning Actually Happens.
The operators who protect their margins do it in June — not November. Book a CFO Discovery Call and we’ll map every H2 deadline, validate your COGS position, and identify what’s still on the table for 2026.
Book Your Free CFO Discovery Call →GreenGrowth CPAs · Cannabis Tax Team
Get more GreenGrowth CPAs insights in Google Search and AI Mode.

